155 related articles for article (PubMed ID: 3144167)
1. Role of adrenergic stimulation by isoproterenol in reversal of effects of encainide in supraventricular tachycardia.
Akhtar M; Niazi I; Naccarelli GV; Tchou P; Rinkenberger R; Dougherty AH; Jazayeri M
Am J Cardiol; 1988 Dec; 62(19):45L-49L. PubMed ID: 3144167
[TBL] [Abstract][Full Text] [Related]
2. Treatment of atrioventricular node reentrant tachycardia with encainide: reversal of drug effect with isoproterenol.
Niazi I; Naccarelli G; Dougherty A; Rinkenberger R; Tchou P; Akhtar M
J Am Coll Cardiol; 1989 Mar; 13(4):904-10. PubMed ID: 2494243
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and electrophysiologic effects of encainide for atrioventricular nodal reentrant tachycardia.
Naccarelli GV; Jackman WM; Akhtar M; Rinkenberger RL; Friday KJ; Dougherty AH; Tchou P; Yeung-Lai-Wah JA
Am J Cardiol; 1988 Dec; 62(19):31L-36L. PubMed ID: 3144165
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic and antiarrhythmic effects of oral encainide in patients with atrioventricular nodal reentry or nodoventricular reentry.
Miles WM; Chang MS; Heger JJ; Rinkenberger RL; Zipes DP; Prystowsky EN
Am Heart J; 1987 Jul; 114(1 Pt 1):26-33. PubMed ID: 3111237
[TBL] [Abstract][Full Text] [Related]
5. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic and clinical effects of oral encainide in paroxysmal atrioventricular node reentrant tachycardia.
Chimienti M; Li Bergolis M; Moizi M; Salerno JA
J Am Coll Cardiol; 1989 Oct; 14(4):992-8. PubMed ID: 2507613
[TBL] [Abstract][Full Text] [Related]
7. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
Jackman WM; Friday KJ; Fitzgerald DM; Yeung-Lai-Wah JA; Lazzara R
Am J Cardiol; 1988 Dec; 62(19):8L-19L. PubMed ID: 3059792
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
[TBL] [Abstract][Full Text] [Related]
10. Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndrome.
Rinkenberger RL; Naccarelli GV; Miles WM; Markel ML; Dougherty AH; Prystowsky EN; Heger JJ; Zipes DP
Am J Cardiol; 1988 Dec; 62(19):26L-30L. PubMed ID: 3144164
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W
Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796
[TBL] [Abstract][Full Text] [Related]
12. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
Kuck KH; Kunze KP; Schlüter M; Duckeck W
Am J Cardiol; 1988 Dec; 62(19):37L-44L. PubMed ID: 3144166
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of incessant supraventricular tachycardia treated with oral encainide.
Brugada P; Wellens HJ
Eur Heart J; 1987 Apr; 8(4):369-71. PubMed ID: 3111853
[TBL] [Abstract][Full Text] [Related]
14. Suppression of incessant supraventricular tachycardia by intravenous and oral encainide.
Brugada P; Abdollah H; Wellens HJ
J Am Coll Cardiol; 1984 Dec; 4(6):1255-60. PubMed ID: 6438205
[TBL] [Abstract][Full Text] [Related]
15. [Anti-arrhythmia and electrophysiological effects of encainide in supraventricular tachycardias].
Cassagneau B; Miquel JP; Puel JP; Mordant B; Kher A; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():113-9. PubMed ID: 3938253
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
Helmy I; Scheinman MM; Herre JM; Sharkey H; Griffin JC
J Am Coll Cardiol; 1990 Dec; 16(7):1649-55. PubMed ID: 2123908
[TBL] [Abstract][Full Text] [Related]
17. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
18. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ
Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251
[TBL] [Abstract][Full Text] [Related]
19. Encainide for resistant supraventricular tachycardia in children: follow-up report.
Strasburger JF; Smith RT; Moak JP; Gothing C; Garson A
Am J Cardiol; 1988 Dec; 62(19):50L-54L. PubMed ID: 3144168
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of isoproterenol in facilitating atrioventricular nodal reentry tachycardia during electrophysiologic testing.
Brownstein SL; Hopson RC; Martins JB; Aschoff AM; Olshansky B; Constantin L; Kienzle MG
Am J Cardiol; 1988 May; 61(13):1037-41. PubMed ID: 2896452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
